Globus Medical, Inc. (NYSE: GMED) will release its first-quarter 2025 financial results on Thursday, May 8, 2025, after ...

Globus Medical (GMED) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the ...

Globus Medical GMED +0.38% Get Free Report has outperformed the market over the past 10 years by 1.4% on an annualized basis ...

Barclays, in a report, says that Abbott (NYSE:ABT) and Baxter (NYSE:BAX) will be among least affected, while Johnson & ...

BTIG lowered the firm’s price target on Globus Medical (GMED) to $88 from $94 and keeps a Buy rating on the shares as part of a broader ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Globus Medical (GMED – Research Report), with a price target of ...

In the assessment of 12-month price targets, analysts unveil insights for Globus Medical, presenting an average target of $90 ...

AUDUBON, Pa., April 03, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, today announced the completion of its previously disclosed acquisition ...

Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release. The acquisition expands Globus Medical’s reach in the musculoskeletal market ...

announced on Monday that it has completed a merger with Globus Medical (NYSE:GMED) Inc., marking a significant change in control of the company. As a result of the merger, Nevro is now a wholly owned ...